The genetic basis of this tumor predisposition syndrome was elucidated in 1998 by Bahuau et al. [9] who reported identification of deletions of the INK4 locus at chromosome 9p21.3 in both of the families described in the original 1993 and 1997 reports. This evidence concerns the gene CDKN2A and BAP1-related tumor predisposition syndrome.